Abstract
Previous studies have shown that N-[(1-ethyl-2-pyrrolidinyl)methyl] )-2-methoxy-5-sulfamoylbenzamide (sulpiride), a psychotrophic drug of clinical use, is a potent antidopaminergic agent, and acts on prolactin and gonadotroph secretions. Cytological changes caused by the effects of this drug were studied in castrated male rats treated with daily doses of sulpiride 5 mg/100 g body weight. Animals were sacrificed 2 months after treatment and their hypophyses processed for cytological and immunohistochemical studies. Cytomorphometry was carried out at the ultrastructural level. An immunocytochemical study was performed with peroxidase-labelled antibody to determine PRL, FSH and LH hormones in gland sections. The administration of sulpiride produced a decrease in granules of prolactin cells. Only the Golgi region showed a positive prolactin reaction and the cytomorphometric study indicated an increase of the area occupied by the endoplasmic reticulum and Golgi complex. In gonadotrophs, treatment with sulpiride decreased the vacuolatin caused by castration. The area occupied by the endoplasmic reticulum was smaller, whereas that occupied by secretion granules and lysosomes became larger. It is suggested that sulpiride treatment increased markedly the mammotroph activity and decreased the gonadotroph one, restoring the vacuolation of the endoplasmic reticulum vacuolation to normal.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
